AXSOME THERAPEUTICS INC revenue for the last year amounted to 245.17 M EUR, the most of which — 245.17 M EUR — came from its highest performing source at the moment, Novel Therapies, the year earlier bringing 46.75 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought AXSOME THERAPEUTICS INC 178.69 M EUR, and the year before that — 46.75 M EUR.